Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ)

CNY 16.42

(-0.61%)

Market Cap (In CNY)

6.22 Billion

Revenue (In CNY)

3.53 Billion

Net Income (In CNY)

174.7 Million

Avg. Volume

35.29 Million

Currency
CNY
Country
Basic Materials
Open
-
Prev. Close
-
Day Range
-
Year Range
10.65-20.5
PE
31.58
EPS
0.52
Beta Value
0.376
ISIN
CNE100001500
CUSIP
-
CIK
-
Shares
379332000.0
Earnings Annoncement
-

Company Profile

Sector
Basic Materials
Industry
Chemicals
CEO
Mr. Jiaquan Li
Employee Count
-
Website
https://www.jinchengpharm.com
Ipo Date
2011-06-22
Details
Shandong Jincheng Pharmaceutical Group Co., Ltd, together with its subsidiaries, researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. The company offers active pharmaceutical ingredients, biopharmaceuticals, medical intermediates, fine chemicals, finished dosages, and pharmaceutical products. It also provides animal nutrition and health care, as well as CMO and CDMO services. The company was founded in 2004 and is based in Zibo, China.